Q BioMed Inc. announced the FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the company’s FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP.   The approval of the facility means that this oncologic pain drug will soon be available to patients in the U.S. and the rest of the world. Q BioMed is now the only FDA-approved source for this drug in the western world. The company is activating its planned commerci...